USPTO gives thumbs up to the California-based companies Augmented Reality (AR) medical application technology. Ocutrx Vision Technologies, LLC announced that their AR glasses, the Oculenz, has been given its first medical patent by the Unite States Patent and Trademark Office (USPTO) for restoring functional sight to patients who have visual field defects. The Oculenz is the first of its kind. “The Oculenz is the first ground-breaking technology to offer a solution for advanced central visual defects in patients with retinal disease,” stated Dr. Thomas Finley, M.D. in the Ocutrx press…
Read More